Search
for

    Products matching "expressivity"

    Tracking 27 products like 107 MINOXIDIL SHAMPOO FR-S1, 108 FR-C1 Conditioner, 109 FOLLICS FR07, 110 FOLLICS FR10 and 111 FOLLICS FR12 from by companies like Minoxidil Express. View all 27 products »

    Learn

    5 / 801 results

    Research

    5 / 96 results

    Community Join

    5 / 1000+ results

      community [AMA] 5-Month Progress Report: Dutasteride and Oral Minoxidil Results.

      in Minoxidil  74 upvotes 5 years ago
      Naepo's 5-month progress report detailing their journey of treating male pattern baldness with dutasteride and oral minoxidil, which has already resulted in an encouraging improvement in hair density. Others have responded with appreciation for the thorough report and asked further questions about Naepo's educational background.

      community topical exosomes - experimenting

      in Treatment  1 upvotes 2 months ago
      The conversation is about experimenting with topical exosomes for hair loss treatment, alongside microneedling, Happy Head's gel-like topical, and Ordinary's hair serum. The user also mentions the availability of treatments like latanoprost and Redensyl.

      community My summation of PP405 - looks promising

      in Research/Science  206 upvotes 1 year ago
      PP405 shows promise for hair regrowth by manipulating stem cell characteristics and lactate dehydrogenase, with Phase 2a trials pending. Google Ventures' $15M investment suggests confidence, but results and market availability remain uncertain.

      community It looks like Pelage are giving hints that PP405 is a game changer

      in Chat  239 upvotes 2 months ago
      PP405 is seen as a potential breakthrough for converting vellus hairs to terminal hairs, with users expressing both hope and skepticism. It is compared to treatments like minoxidil and finasteride, with discussions on side effects and marketing concerns.

      community PP405 (Non) Update - Feb 2025

      in Research/Science  34 upvotes 1 year ago
      The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.